Obstructive Sleep Apnea, Obesity Hypoventilation Syndrome, and Pulmonary Hypertension: A State-of-the-Art Review

Sleep Med Clin. 2024 Jun;19(2):307-325. doi: 10.1016/j.jsmc.2024.02.009. Epub 2024 Mar 12.

Abstract

The pathophysiological interplay between sleep-disordered breathing (SDB) and pulmonary hypertension (PH) is complex and can involve a variety of mechanisms by which SDB can worsen PH. These mechanistic pathways include wide swings in intrathoracic pressure while breathing against an occluded upper airway, intermittent and/or sustained hypoxemia, acute and/or chronic hypercapnia, and obesity. In this review, we discuss how the downstream consequences of SDB can adversely impact PH, the challenges in accurately diagnosing and classifying PH in the severely obese, and review the limited literature assessing the effect of treating obesity, obstructive sleep apnea, and obesity hypoventilation syndrome on PH.

Keywords: Bilevel PAP; CPAP; Echocardiogram; Hypercapnia; Hypoxemia; Noninvasive ventilation; Obesity hypoventilation syndrome; Obstructive sleep apnea; Positive airway pressure therapy; Pulmonary arterial hypertension; Pulmonary artery systolic pressure; Pulmonary hypertension; Right heart catheterization; Right ventricular systolic pressure; Sleep disordered breathing.

Publication types

  • Review

MeSH terms

  • Humans
  • Hypertension, Pulmonary* / diagnosis
  • Hypertension, Pulmonary* / physiopathology
  • Hypertension, Pulmonary* / therapy
  • Obesity Hypoventilation Syndrome* / diagnosis
  • Obesity Hypoventilation Syndrome* / physiopathology
  • Obesity Hypoventilation Syndrome* / therapy
  • Sleep Apnea, Obstructive* / complications
  • Sleep Apnea, Obstructive* / diagnosis
  • Sleep Apnea, Obstructive* / physiopathology
  • Sleep Apnea, Obstructive* / therapy